erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
.
. may 15, 2018
.
letter exposes 22 lab animal deaths at uc berkeley from 2015 to 2017
.treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk (file pic)
.
scottish widows deal with zurich shows pensions commitment
.